Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

About Me

Experienced biotechnology executive, with demonstrated history as CEO, Chairman and Board member. Over twenty years as an executive in the biotechnology industry which include 12 years as President & CEO of Protalix Biotherapeutics, leading it to FDA drug approval (Elelyso for treating Gaucher Disease) and Wall Street listing (NYSE). Skilled in drug developmemt, privete and public market financing, FDA, GMP production and clinical trials. Strong business development and strategic planning professional. Ph.D. in Biochemistray & Molecular Biology from the Weizmann Institute of Science as well as an MBA from Bar Ilan university.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Education/Academic qualification

… → Jan 1996


Dive into the research topics where David Aviezer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles